Equities research analysts expect Celestica Inc (NYSE:CLS) (TSE:CLS) to post $1.47 billion in sales for the current quarter, Zacks reports. Two analysts have issued estimates for Celestica’s earnings. Celestica also reported sales of $1.47 billion in the same quarter last year. The business is expected to announce its next earnings report on Thursday, April 19th.
On average, analysts expect that Celestica will report full-year sales of $1.47 billion for the current fiscal year, with estimates ranging from $6.20 billion to $6.25 billion. For the next year, analysts anticipate that the business will post sales of $6.45 billion per share. Zacks’ sales averages are an average based on a survey of sell-side analysts that that provide coverage for Celestica.
Celestica (NYSE:CLS) (TSE:CLS) last posted its quarterly earnings results on Wednesday, January 24th. The technology company reported $0.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.20 by ($0.10). Celestica had a return on equity of 8.84% and a net margin of 1.72%. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.56 billion.
Celestica (NYSE:CLS) opened at $10.66 on Thursday. Celestica has a 12-month low of $9.79 and a 12-month high of $14.74. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.94 and a quick ratio of 1.10. The stock has a market capitalization of $1,530.00, a price-to-earnings ratio of 14.81 and a beta of 0.71.
Celestica announced that its Board of Directors has approved a stock buyback program on Thursday, October 26th that allows the company to buyback 1,000% of outstanding shares. This buyback authorization allows the technology company to buy shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.
A number of institutional investors have recently modified their holdings of CLS. Brandes Investment Partners LP acquired a new stake in Celestica during the 4th quarter worth $38,239,000. Burgundy Asset Management Ltd. acquired a new stake in Celestica during the 4th quarter worth $10,769,000. Royce & Associates LP raised its stake in Celestica by 27.5% during the 4th quarter. Royce & Associates LP now owns 3,961,789 shares of the technology company’s stock worth $41,520,000 after buying an additional 854,186 shares during the period. Donald Smith & CO. Inc. raised its stake in Celestica by 25.8% during the 4th quarter. Donald Smith & CO. Inc. now owns 3,443,245 shares of the technology company’s stock worth $36,085,000 after buying an additional 706,521 shares during the period. Finally, Mackenzie Financial Corp raised its stake in Celestica by 16.4% during the 4th quarter. Mackenzie Financial Corp now owns 3,271,532 shares of the technology company’s stock worth $34,286,000 after buying an additional 460,294 shares during the period. 66.80% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “$1.47 Billion in Sales Expected for Celestica Inc (CLS) This Quarter” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/02/15/1-47-billion-in-sales-expected-for-celestica-inc-cls-this-quarter.html.
Celestica Company Profile
Celestica Inc is a provider of supply chain solutions. The Company operates in electronics manufacturing services business segment. The Company offers a range of services to its customers, including design and development, engineering services, supply chain management, new product introduction, component sourcing, electronics manufacturing, assembly and test, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics and after-market repair and return services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.